Based on last week’s closing prices, the plan would authorize the purchase of about 4 million shares, or 1.2 percent of the company’s shares outstanding.
The repurchasing plan aims to help offset dilution created by future equity grants. The repurchasing will be funded from working capital, according to a 4-traders report.
“At current prices, we believe the repurchase of our stock is a good use of funds,” said Neal Patterson, Cerner’s chairman, CEO and co-founder, in the report. “This program reflects our commitment to enhancing long-term shareholder value and our confidence in Cerner’s prospects as a leader in the growing healthcare industry.”
More Articles on the Health IT Market:
Trinity Medical Center Settlement Forces Cerner to Take Charge Against Anticipated Earnings
athenahealth Shares Plummet on Poor 2014 Outlook
8 Recent Health IT Market Stories
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.